|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-7-20
|
|
pubmed:abstractText |
To study the efficacy of omeprazole triple therapy in the eradication of Helicobacter pylori in patients with active gastric ulcer, and to assess healing and relapse of gastric ulcer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:BayerdörfferEE,
pubmed-author:DieteUU,
pubmed-author:GilJJ,
pubmed-author:LindTT,
pubmed-author:MalfertheinerPP,
pubmed-author:MisiunaPP,
pubmed-author:O'MorainCC,
pubmed-author:SipponenPP,
pubmed-author:SpillerR CRC,
pubmed-author:StasiewiczJJ,
pubmed-author:TreichelHH,
pubmed-author:UjszászyLL,
pubmed-author:UngePP,
pubmed-author:ZantenS JSJ,
pubmed-author:ZeijlonLL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
703-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10383498-Adult,
pubmed-meshheading:10383498-Aged,
pubmed-meshheading:10383498-Anti-Ulcer Agents,
pubmed-meshheading:10383498-Double-Blind Method,
pubmed-meshheading:10383498-Female,
pubmed-meshheading:10383498-Helicobacter Infections,
pubmed-meshheading:10383498-Helicobacter pylori,
pubmed-meshheading:10383498-Humans,
pubmed-meshheading:10383498-Male,
pubmed-meshheading:10383498-Middle Aged,
pubmed-meshheading:10383498-Omeprazole,
pubmed-meshheading:10383498-Patient Compliance,
pubmed-meshheading:10383498-Recurrence,
pubmed-meshheading:10383498-Stomach Ulcer
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer.
|
|
pubmed:affiliation |
Universitätsklinik Otto-von-Guericke, Magdeburg, Germany. peter.malfertheiner@medizin.uni-magdeburg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
